Microbot Medical Inc. (MBOT) stock
MBOTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.69+0.04 (+6.92%)
Close on Nov 17, 2026Market cap $46.28MP/E –Yield –
Microbot Medical r&d expenses
Research and development expenses are spending on new products and technology.
Microbot Medical's R&D Expenses for the twelve months ending Jun 30, 2026 was $5.87M, down 22.9% year over year. For fiscal 2025 it was $6.28M, down 5.2% from the year before. The highest annual figure on record is $21.50M in fiscal 2014.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.28M | -5.2% |
| FY2024 | Dec 31, 2024 | $6.63M | +15.8% |
| FY2023 | Dec 31, 2023 | $5.72M | -26.0% |
| FY2022 | Dec 31, 2022 | $7.74M | +25.7% |
| FY2021 | Dec 31, 2021 | $6.15M | +81.2% |
| FY2020 | Dec 31, 2020 | $3.40M | +11.4% |
| FY2019 | Dec 31, 2019 | $3.05M | +21.2% |
| FY2018 | Dec 31, 2018 | $2.52M | +128.6% |
| FY2017 | Dec 31, 2017 | $1.10M | – |
| FY2016 | Dec 31, 2016 | -$901.00K | – |
| FY2015 | Dec 31, 2015 | -$823.00K | -103.8% |
| FY2014 | Dec 31, 2014 | $21.50M | +11.0% |
| FY2013 | Dec 31, 2013 | $19.37M | +31.9% |
| FY2012 | Dec 31, 2012 | $14.68M | -26.4% |
| FY2011 | Dec 31, 2011 | $19.94M | -5.1% |
| FY2010 | Dec 31, 2010 | $21.02M | +5.5% |
| FY2009 | Dec 31, 2009 | $19.93M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.86M | -11.8% |
| Q1 FY2026 | Mar 31, 2026 | $1.29M | -11.4% |
| Q4 FY2025 | Dec 31, 2025 | $1.54M | -22.3% |
| Q3 FY2025 | Sep 30, 2025 | $1.17M | -43.2% |
| Q2 FY2025 | Jun 30, 2025 | $2.11M | +49.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.46M | +24.8% |
| Q4 FY2024 | Dec 31, 2024 | $1.98M | +75.6% |
| Q3 FY2024 | Sep 30, 2024 | $2.06M | +27.8% |
| Q2 FY2024 | Jun 30, 2024 | $1.42M | +3.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.17M | -27.7% |
| Q4 FY2023 | Dec 31, 2023 | $1.13M | -48.5% |
| Q3 FY2023 | Sep 30, 2023 | $1.61M | -5.5% |
| Q2 FY2023 | Jun 30, 2023 | $1.37M | -39.5% |
| Q1 FY2023 | Mar 31, 2023 | $1.62M | +16.4% |
| Q2 FY2022 | Jun 30, 2022 | $2.19M | +57.9% |
| Q1 FY2022 | Mar 31, 2022 | $1.71M | +52.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.26M | +125.8% |
| Q3 FY2021 | Sep 30, 2021 | $1.39M | +33.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.39M | +107.6% |
| Q1 FY2021 | Mar 31, 2021 | $1.12M | +61.9% |
| Q4 FY2020 | Dec 31, 2020 | $999.00K | +18.8% |
| Q3 FY2020 | Sep 30, 2020 | $1.04M | +23.0% |
| Q2 FY2020 | Jun 30, 2020 | $669.00K | -9.7% |
| Q1 FY2020 | Mar 31, 2020 | $691.00K | +17.7% |
| Q4 FY2019 | Dec 31, 2019 | $841.00K | +29.6% |
| Q3 FY2019 | Sep 30, 2019 | $843.00K | +35.3% |
| Q2 FY2019 | Jun 30, 2019 | $741.00K | -0.8% |
| Q1 FY2019 | Mar 31, 2019 | $587.00K | +18.3% |
| Q4 FY2018 | Dec 31, 2018 | $649.00K | +224.5% |
| Q3 FY2018 | Sep 30, 2018 | $623.00K | +83.8% |
| Q2 FY2018 | Jun 30, 2018 | $747.00K | +98.1% |
| Q1 FY2018 | Mar 31, 2018 | $496.00K | +169.6% |
| Q4 FY2017 | Dec 31, 2017 | $200.00K | – |
| Q3 FY2017 | Sep 30, 2017 | $339.00K | – |
| Q2 FY2017 | Jun 30, 2017 | $377.00K | – |
| Q1 FY2017 | Mar 31, 2017 | $184.00K | – |
| Q3 FY2016 | Sep 30, 2016 | -$340.00K | – |
| Q2 FY2016 | Jun 30, 2016 | -$44.00K | – |
See a number that looks wrong?